Pharmaceutical Technology in Hospital Pharmacy (Jun 2018)

Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspension in Syrspend® SF PH4

  • Bonnaure Anne-Claire,
  • Bellay Romain,
  • Rault Pauline,
  • Lester Marie-Antoinette,
  • Boivin Pierre-Nicolas

DOI
https://doi.org/10.1515/pthp-2018-0001
Journal volume & issue
Vol. 3, no. 2
pp. 49 – 57

Abstract

Read online

Prednisone is a corticosteroid used in several inflammatory diseases and cancers. In France, no available prednisone drinkable formulation exists. Instead, an oral syrup of prednisone with ethanol, sodium benzoate and simple syrup is produced. However, sodium benzoate can induce neonatal icterus and alcohol is not authorized for children below 3 years of age. The aim of this study was to determine the stability of 5 mg/mL prednisone oral suspension in a commercial compounding excipient: Syrspend® SF PH4.

Keywords